In this podcast we interview Paul Dragsten. Paul is the Vice President of Research and Development for Biomedical Frontiers, a small Minneapolis based bio tech company working on an orphan drug to treat thalassemia, a genetic defect that causes them to make defective hemoglobin.
Wednesday, April 22, 2009
Paul Dragsten Interview
In this podcast we interview Paul Dragsten. Paul is the Vice President of Research and Development for Biomedical Frontiers, a small Minneapolis based bio tech company working on an orphan drug to treat thalassemia, a genetic defect that causes them to make defective hemoglobin.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment